Vaccines targeting ESR1 activating mutations elicit anti-tumor immune responses and suppress estrogen signaling in therapy resistant ER+ breast cancer.
- Resource Type
- Article
- Authors
- Dailey, Gabrielle P.; Rabiola, Christopher A.; Lei, Gangjun; Wei, Junping; Yang, Xiao-Yi; Wang, Tao; Liu, Cong-Xiao; Gajda, Melissa; Hobeika, Amy C.; Summers, Amanda; Marek, Robert D.; Morse, Michael A.; Lyerly, Herbert K.; Crosby, Erika J.; Hartman, Zachary C.
- Source
- Human Vaccines & Immunotherapeutics; 2024, Vol. 20 Issue 1, p1-10, 10p
- Subject
- Language
- ISSN
- 21645515